Scientists test old drug to unlock fatty liver mystery
NCT ID NCT05729282
Summary
This small, early-stage study aimed to understand if lowering high insulin levels could affect how the liver handles fat in people with fatty liver disease. For two weeks, 24 adults with overweight/obesity and insulin resistance took either a drug called diazoxide or a placebo. Researchers measured blood sugar, insulin, and fats to see if reducing insulin changed how the liver makes new fat.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INSULIN RESISTANCE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Columbia University Irving Medical Center
New York, New York, 10032, United States
Conditions
Explore the condition pages connected to this study.